Applications of Polymeric and Lipid Nanoparticles in Ophthalmic Pharmaceutical Formulations: Present and Future Considerations

被引:83
作者
Almeida, Hugo [1 ]
Amaral, Maria Helena [1 ]
Lobao, Paulo [1 ]
Silva, Ana C. [1 ,2 ]
Sousa Lobo, Jose Manuel [1 ]
机构
[1] Univ Porto, Fac Pharm, Res Ctr Pharmaceut Sci, Drug Sci Dept,Lab Pharmaceut Technol, P-4050313 Oporto, Portugal
[2] Fernando Pessoa Univ, Fac Hlth Sci, Oporto, Portugal
关键词
OCULAR DRUG-DELIVERY; IN-VITRO RELEASE; SITU GELLING SYSTEMS; PHYSICOCHEMICAL CHARACTERIZATION; CHITOSAN NANOPARTICLES; CYCLOSPORINE-A; RESPONSIVE POLYMERS; POTENTIAL APPROACH; CARRIERS NLC; TOPICAL USE;
D O I
10.18433/J3DP43
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The unique properties and characteristics of ocular tissues and the whole set of defence mechanisms of the ocular globe make the instillation of ocular drugs into a difficult task with a low rate of therapeutic response. One of the challenges for the new generation of ophthalmic pharmaceutical formulations is to increase the bioavailability of drugs administered by the ocular route and, therefore, their therapeutic efficacy. This can be achieved with the use of some strategies that provide an increase in the formulation pre-corneal residence time, mucoadhesion and penetration across the eye tissues. Colloidal carrier systems have been very successfully used for the selective and targeted delivery of drugs for several routes of administration. In this context, nanoparticles prepared with specific polymers or lipids and coated, dispersed or suspended in polymer solutions with mucoadhesion properties or in situ gelling properties will be an excellent strategy that deserves attention and further research. In this review, the characteristics and main properties of polymeric and lipid nanoparticles are discussed and examples and advantages of the application of these colloidal carrier systems for the ophthalmic administration of drugs are presented. The future directions of the research required in this specific field are also presented.
引用
收藏
页码:278 / 293
页数:16
相关论文
共 115 条
[81]  
Nirmal HB., 2010, INT J PHARM TECH RES, V2, P1398
[82]   Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages -: impact of phagocytosis on viability and cytokine production [J].
Olbrich, C ;
Schöler, N ;
Tabatt, K ;
Kayser, O ;
Müller, RH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (07) :883-891
[83]  
Patil BB, 2000, CURR ANAESTH CRIT CA, V11, P293
[84]   Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application [J].
Pignatello, R ;
Bucolo, C ;
Spedalieri, G ;
Maltese, A ;
Puglisi, G .
BIOMATERIALS, 2002, 23 (15) :3247-3255
[85]   Studies on a new device for drug delivery to the eye [J].
Pijls, RT ;
Sonderkamp, T ;
Daube, GW ;
Krebber, R ;
Hanssen, HHL ;
Nuijts, RMMA ;
Koole, LH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (02) :283-288
[86]   Ocular anatomy and physiology relevant to anaesthesia [J].
Presland, Andrew ;
Myatt, John .
ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2010, 11 (10) :438-443
[87]  
Prista L N., 2002, Tecnologia Farmaceutica, V6a
[88]   Poloxamine micellar solubilization of α-tocopherol for topical ocular treatment [J].
Ribeiro, Andreza ;
Sandez-Macho, Isabel ;
Casas, Matilde ;
Alvarez-Perez, Susana ;
Alvarez-Lorenzo, Carmen ;
Concheiro, Angel .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 103 :550-557
[89]   The ocular surface and tear film and their dysfunction in dry eye disease [J].
Rolando, M ;
Zierhut, M .
SURVEY OF OPHTHALMOLOGY, 2001, 45 :S203-S210
[90]   Smart polymeric materials: Emerging biochemical applications [J].
Roy, I ;
Gupta, MN .
CHEMISTRY & BIOLOGY, 2003, 10 (12) :1161-1171